In this article

AZN-GB

Follow your favorite stocks CREATE FREE ACCOUNT

The Trump administration and AstraZeneca announced Friday they have reached an agreement for the U.K.-based pharmaceutical giant to cut drug prices in the U.S.

The deal with AstraZeneca follows a similar pact with U.S. drugmaker Pfizer , which was announced late last month.

AstraZeneca will agree to sell drugs directly to Medicaid patients at the lowest price offered in other developed countries, or what Trump calls "most-favored nation" pricing, on a coming government website called TrumpRx.gov. AstraZeneca's primary care medications will be available on the site starting early next year, and the company will offer new prescription medications at most-favored nation pricing, said Centers fo

See Full Page